Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma

類似資料

• Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
  著者:: Fayette, Jérôme, 等
  出版事項: (2015)
• Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
  著者:: Tahara, Makoto, 等
  出版事項: (2014)
• The Importance of Panitumumab in Radiotherapy Involving Head and Neck Region
  著者:: Cihan, Yasemin Benderli
  出版事項: (2018)
• Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma
  著者:: Grossberg, Aaron J., 等
  出版事項: (2016)
• Prediction of Locoregional Control in Head and Neck Squamous Cell Carcinoma with Serial CT Perfusion during Radiotherapy
  著者:: Truong, M.T., 等
  出版事項: (2011)